Irradiation and taxol tretment result in non-monotonous dose-dependent changes in the motility of glioblastoma cells

Journal of Neuro-Oncology

Volumn 67, Issue 1-2, 2004, Pages 147-157

  Hegedus, Balázs ^a,b   Zách, Júlia ^a   Czirók, András ^a,d   Lövey, József ^c   Vicsek, Tamás ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b NATIONAL INSTITUTE OF NEUROSURGERY   (Hungary)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cell migration; Glioblastoma; Paclitaxel; Radiotherapy

Indexed keywords

PACLITAXEL; RADIOSENSITIZING AGENT; VERAPAMIL; ACTIN; ANTINEOPLASTIC AGENT;

ARTICLE; AUTOMATION; CALCULATION; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CARCINOGENICITY; CELL FRACTIONATION; CELL MIGRATION; CELL MOTILITY; CELL MOTION; CELL POPULATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; LOW ENERGY RADIATION; MONITORING; MULTIDRUG RESISTANCE; PROGNOSIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSENSITIZATION; SCANNING ELECTRON MICROSCOPY; TIME; TREATMENT OUTCOME; TUMOR CELL CULTURE; TUMOR CELL LINE; TWO DIMENSIONAL ELECTROPHORESIS; VELOCITY; VIDEORECORDING; DOSE RESPONSE; DRUG EFFECT; MICROSCOPY; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY;

ACTINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL MOVEMENT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; GLIOBLASTOMA; HUMANS; MICROSCOPY, VIDEO; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY;

EID: 1842432442     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000021826.73020.f3     Document Type: Article

References (42)

1. Souhami L, Olivier A, Podgorsak EB, Villemure JG, Pla M, Sadikot AF: Fractionated stereotactic radiation therapy for intracranial tumors. Cancer 68: 2101-2108, 1991
2. Hudes RS, Corn BW, Werner-Wasik M, Andrews D, Rosenstock J, Thoron L, Downes B, Curran WJ Jr: A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 43: 293-298, 1999
3. Lederman G, Arbit E, Odaimi M, Lombardi E, Wrzolek M, Wronski M: Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report. Int J Rad Oncol Biol Phys 40: 661-666, 1998
4. Lederman G, Wronski M, Arbit E, Odaimi M, Wertheim S, Lombardi E, Wrzolek M: Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 23: 155-159, 2000
5. Iwadate Y, Fujimoto S, Yamaura A: Differential chemosensitivity in human intracerebral gliomas measured by flow cytometric DNA analysis. Int J Mol Med 10: 187-192, 2002
6. Taghian A, Suit H, Pardo F, Gioioso D, Tomkinson K, DuBois W, and Gerweck L: In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 23: 55-62, 1992
7. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W: Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744-2750, 2001
8. Bauman GS, MacDonald W, Moore E, Ramsey DA, Fisher BJ, Amberger VR, Del Maestro RM: Effects of radiation on a model of malignant glioma invasion. J Neuro-Oncol 44: 223-231, 1999
9. Tishler RB, Geard CR, Hall EJ, Schiff PB: Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52: 3495-3497, 1992
10. Blagosklonny MV, Fojo T: Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer 83: 151-1565, 1999
11. Ballestrem C, Wehrle-Haller B, Hinz B, Imhof BA: Actin-dependent lamellipodia formation and microtubule-dependent tail retraction control-directed cell migration. Mol Biol Cell 11: 2999-3012, 2000
12. Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H, Gundersen G: Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. Br J Cancer 75: 1744-1752, 1997
13. Silbergeld DL, Chicoine MR, Madsen CL: In vitro assessment of Taxol for human glioblastoma: chemosensitivity and cellular locomotion. Anticancer Drugs 6: 270-276, 1995
14. Chicoine MR, Silbergeld DL: The in vitro motility of human gliomas increases with increasing grade of malignancy. Cancer 75: 2904-2909, 1995
15. Hegedüs B, Czirók A, Fazekas I, Bábel T, Madarász E, Vicsek T: Locomotion and proliferation of glioblastoma cells in vitro: statistical evaluation of videomicroscopic observations. J Neurosurg 92: 428-434, 2000
16. Fazekas I, Kerekes E, Hegedüs B, Nyáry I: Identification of gliomas by morphological and immunocytochemical analysis in cell cultures. Ideggy Szemle 55: 173-180, 2002
17. Homolya L, Holló Z, Müller M, Mechetner EB, Sarkadi B: A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Br J Cancer 73: 849-855, 1996
18. Holló Z, Homolya L, Hegedüs T, Sarkadi B: Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Lett 383: 99-104, 1996
19. Czirók A, Rupp PA, Rongish BJ, Little CD: Multifield 3D scanning light microscopy of early embryogenesis. J Microsc 206: 209-217, 2002
20. Czirók A, Schlett K, Madarász E, Vicsek T: Exponential distribution of locomotion activity in cell cultures. Phys Rev Lett 81: 3038-3041, 1998
21. Stokes CL, Lauffenburger DA, William SK: Migration of individual microvessel endothelial cells: stochastic model and parameter measurement. J Cell Sci 99: 419-430, 1991
22. Méhes E, Czirók A, Hegedüs B, Vicsek T, Jancsik V: Laminin-1 increases motility, path-searching and process dynamism of rat and mouse Muller glial cells in vitro; implication of relationship between cell behavior and formation of retinal morphology. Cell Motil Cytoskel 53: 203-213, 2002
23. Jang SH, Wientjes MG, Au JL: Kinetics of P-glycoprotein-mediated efflux of paclitaxel. J Pharmacol Exp Ther 298: 1236-1242, 2001
24. Lunzford LD, Somaza S, Kondziolka D, Flickinger JC: Brain astrocytomas: biopsy, then irradiation. Clin Neurosurg 42: 464-479, 1995
25. Belot N, Rorive S, Doyen I, Lefranc F, Bruyneel E, Dedecker R, Micik S, Brotchi J, Decaestecker C, Salmon I, Kiss R, Camby I: Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features. Glia 36: 375-390, 2001
26. Wild-Bode C, Weller M, Wick W: Molecular determinants of glioma cell migration and invasion. J Neurosurg 94: 978-984, 2001
27. Pomerat CM, Kent SP, Logie LC: Irradiation of cells in tissue culture II. Cinematographic analyses of cell enlargement and mitotic activity following gamma irradiation at 2000 r and 4000 r. Zeitschrift für Zellforschung 47: 175-197, 1957
28. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B: Mutations of mitotic checkpoint genes in human cancers. Nature 392: 300-303, 1998
29. Pomerat CM, Kent SP, Logie LC: Irradiation of cells in tissue culture I. Giant cell induction in strain cultures versus elements from primary explants. Zeitschrift für Zellforschung 47: 158-174, 1957
30. Bernstein JJ, Goldberg WJ, Laws ER Jr: Human malignant astrocytoma xenografts migrate in rat brain: a model for central nervous system cancer research of human glial and glioma cells in culture. J Neurosci Res 22: 134-143, 1989
31. Huang P, Allam A, Taghian A: Growth and metastatic behavior of five human glioblastoma compared with nine other histological types of human tumor xenografts in SCID mouse. J Neurosurg 83: 308-315, 1995
32. Chicoine MR, Silbergeld DL: Assessment of brain tumor cell motility in vivo and in vitro. J Neurosurg 82: 615-622, 1995
33. Chicoine MR, Silbergeld DL: Mitogens as motogens. J Neuro-Oncol 35: 249-257, 1997
34. Hartmann-Petersen R, Walmond PS, Berezin A, Berezin V, Bock E: Individual cell motility studied by time-lapse video recording: influence of experimental conditions. Cytometry 40: 260-270, 2000
35. Engebraaten O, Schwachenwald R, Valen H, Bjerkvig R, Laerum OD, Backlund EO: Effects of high and low single dose radiation on glioma spheroid invasion into normal rat brain tissue in vitro. Anticancer Res 12: 1501-1506, 1992
36. Olive PL: The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. Radiat Res 150: 42-51, 1998
37. Hamberg H, Brunk UT, Ericsson JLE, Jung B: Cytoplasmic effects of X-irradiation on cultured cells in a non-dividing stage. 3. Alterations in plasma membrane motility. Acta Pathol Microbiol Scand 86: 487-494, 1978
38. Kamiryo T, Kassell NF, Thai QA, Lopes MBS, Lee KS, Steiner L: Histological changes in the normal rat brain after gamma irradiation. Acta Neurochir 138: 451-459, 1996
39. Stammler G, Pommerenke EW, Masanek U, Mattern J, Volm M: Messenger RNA expression of resistance factors in human tumor cell lines after single exposure to radiation. J Exp Ther Oncol 1: 39-48, 1996
40. Huizing MT, Keung AC, Rosing H, van der Kuij V, ten Bokkel Huinink WW, Mandjes IM, Dubbelman AC, Pinedo HM, Beijnen JH: Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. J Clin Oncol 11: 2127-2135, 1993
41. Mohri M, Nitta H, Yamashita J: Expression of multidrug resistance-associated protein (MRP) in human gliomas. J Neuro-Oncol 49: 105-115, 2001
42. Becker I, Becker KF, Meyermann R, Höllt V: The multidrug-resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol 82: 516-519, 1991